Well I think seeing how long-lasting the survival benefit of early exposure to Pemberley zoo map is in the recurrent metastatic setting makes me very keen to see how it’s going to work in the definitive setting and there are studies ongoing looking at it in combination with chemotherapy and radiation in the definitive setting in eastern cooperative Oncology Group Akron.

Network were activating a trial for intermediate risk HPV associated disease we’re following the.

Completion of chemo radiation patients will randomly be assigned to nivolumab or observation and there are numerous studies.

Going forward with other drugs in the class so I do think that you’ll see more.

And more studies looking at the impact of immune checkpoint inhibitors in the definitive settings.

LEAVE A REPLY

Please enter your comment!
Please enter your name here